ELISA for Metabolic Syndrome Biomarkers | BioVendor #09

BioVendor’s Biomarker Selection in Metabolic syndrome, Obesity and Type 2 Diabetes.

Here, we discuss the complexity of metabolic syndrome, its relation to civilization diseases and what protein biomarkers are behind it.

In this presentation we pay special attention to Adiponectin, FGF21 and FGF19, Adipocyte FABP (FABP4), and PCSK9. We describe their role in the development of metabolic syndrome, T2DM, lipoprotein metabolism disorders, CVD, atherosclerosis, renal disease, and carcinomas.

Learn what markers we consider the most relevant for both diagnostic and research purpose and what ELISA kits we can offer.